U. Vanhoefer

Final Results of a Randomized Phase III Trial of Sequential High-Dose Methotrexate, Fluorouracil, and Doxorubicin Versus Etoposide, Leucovorin, and Fluorouracil Versus Infusional Fluorouracil and Cisplatin in Advanced Gastric Cancer: A Trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group

U. Vanhoefer, Philippe Rougier, H. Wilke et al. · Journal of Clinical Oncology · 2000 · 533 citations

Phase III Study of Weekly High-Dose Infusional Fluorouracil Plus Folinic Acid With or Without Irinotecan in Patients With Metastatic Colorectal Cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986

Claus Henning Köhne, Eric Van Cutsem, J. Wils et al. · Journal of Clinical Oncology · 2005 · 329 citations

Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor Receptor

U. Vanhoefer, Mitra Tewes, Federico Rojo et al. · Journal of Clinical Oncology · 2003 · 259 citations

D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity.

Gerald Bacher, B Nickel, Peter Emig et al. · PubMed · 2001 · 142 citations

Tumor Biology, Oncology, Medicine +13

Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584

Aurélie Thomas, Bruno Morgan, Joachim Drevs et al. · Seminars in Oncology · 2003 · 97 citations

Endothelial Cell Pathobiology, Angiogenesis, Ptk787/zk 222584 +10